HBM Healthcare Investments (Cayman) Ltd.
CIK 1232258 · last filed 2023-02-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$326.19M
Companies
9
Total Filings
54
Lifetime Open-Market Net
-$16.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MLYS | 10%+ Owner | 3,218,106 | $26.35 | $84.80M | $5.00M | 1 | 2023-02-16 |
| IO Biotech, Inc. (IOBT) Delisted | 10%+ Owner | 2,365,545 | $0.05 | $113.5K | $4.55M | 1 | 2021-11-12 |
| HOWL | 10%+ Owner | 625,995 | $0.47 | $293.5K | $0 | 1 | 2021-05-05 |
| Nabriva Therapeutics plc (NBRV) Delisted | 10%+ Owner | 9,337 | $1.42 | $13.3K | -$4.13M | 15 | 2017-09-14 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | 10%+ Owner | 1,757,680 | $2.23 | $3.92M | -$632.9K | 1 | 2015-06-01 |
| PTCT | 10%+ Owner | 2,441,504 | $74.52 | $181.94M | $8.73M | 2 | 2013-12-19 |
| IVERIC bio, Inc. (OPHT) Delisted | 10%+ Owner | 2,806,937 | — | — | $5.02M | 1 | 2013-10-03 |
| PCRX | 10%+ Owner | 2,233,993 | $26.48 | $59.16M | -$27.84M | 4 | 2013-03-25 |
| MICRUS ENDOVASCULAR CORP (MEND) Delisted | 10%+ Owner | 1,635,403 | — | — | -$7.06M | 24 | 2010-03-04 |
Recent Filings · Page 3 of 6
54 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-11 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −90,594 | -$992.5K | EDGAR |
| 2017-04-10 | Nabriva Therapeutics plc (NBRV) Delisted | Sell (S) | −90,594 | -$992.5K | EDGAR |
| 2015-06-01 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Sell (S) | −20,580 | -$632.9K | EDGAR |
| 2013-12-19 | PTCT | Sell (S) | −66,667 | -$1.27M | EDGAR |
| 2013-10-03 | IVERIC bio, Inc. (OPHT) Delisted | Mixed | +3,639,901 | $5.02M | EDGAR |
| 2013-06-28 | PTCT | Mixed | +2,508,171 | $10.00M | EDGAR |
| 2013-03-25 | PCRX | Sell (S) | −290,900 | -$8.13M | EDGAR |
| 2013-03-21 | PCRX | Sell (S) | −909,100 | -$25.46M | EDGAR |
| 2011-11-22 | PCRX | Buy (P) | +307,692 | $2.00M | EDGAR |
| 2011-02-10 | PCRX | Mixed | +3,044,617 | $17.48M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.